Editorial: Elimination of biliary atresia
Résumé
future research. The future research needed to fill the gap of knowledge include: the potential of genetic neonatal screening according to racial geographic known susceptibility genes, the outcome of BA if immune-modulatory therapy is instituted within the earliest 2-4 weeks, the role of enzyme replacement of missing enzymes as GSTM1, defining the protective gene against BA in Down syndrome patients, defining if this protective gene is amenable to gene therapy among the other children, the role of environmental control of aflatoxin contamination of foods, the role of abandoning milking of the umbilical cord at delivery, the ideal timing and type of immune modulatory medicine for BA. More insight in BA susceptibility, etiology, screening, management, natural history, treatment, transplantation challenges, outcome, burden and prevention is needed to plan BA eradication.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 26/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →